Protagenic Therapeutics Inc(PTIX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PTIX Protagenic Therapeutics Inc

Closed 04-01 16:00:00 EDT

0.2500

+0.0549

+28.14%

盘后0.2500

+0.00000.00%

19:54 EDT

High0.2782	Low0.1790	Vol699.54K
Open0.1790	D1 Closing0.1951	Amplitude50.85%
Mkt Cap1.81M	Tradable Cap1.57M	Total Shares7.24M
T/O165.75K	T/O Rate11.16%	Tradable Shares6.27M
P/B2.52	ROE-231.87%	EPS-1.27
52wk High1.87	52wk Low0.1790	P/E-0.20
Dividend0.00	Div.Yield0.00	ROA-94.91%

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"PTIX","market":"US","secType":"STK","nameCN":"Protagenic Therapeutics Inc","latestPrice":0.25,"timestamp":1743537600000,"preClose":0.1951,"halted":0,"volume":699537,"hourTrading":{"tag":"盘后","latestPrice":0.25,"preClose":0.25,"latestTime":"19:54 EDT","volume":81045,"amount":21232.4578,"timestamp":1743551644913},"delay":0,"floatShares":6269024,"shares":7241440,"eps":-1.26899,"marketStatus":"Closed","change":0.0549,"latestTime":"04-01 16:00:00 EDT","open":0.179,"high":0.2782,"low":0.179,"amount":165750.75215487,"amplitude":0.508457,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.26899,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1743580800000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":0.1951,"postHourTrading":{"tag":"盘后","latestPrice":0.25,"preClose":0.25,"latestTime":"19:54 EDT","volume":81045,"amount":21232.4578,"timestamp":1743551644913},"volumeRatio":11.637924},"requestUrl":"/m/hq/s/PTIX/tweets","defaultTab":"tweets","newsList":[{"id":"2502085600","title":"BRIEF-Protagenic Therapeutics - May Offer And Sell, From Time To Time, Shares Of  Common Stock Of Up To $1.2 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2502085600","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502085600?lang=en_us&edition=full_marsco","pubTime":"2025-01-10 19:17","pubTimestamp":1736507830,"startTime":"0","endTime":"0","summary":"Jan 10 (Reuters) - Protagenic Therapeutics Inc   :   * PROTAGENIC THERAPEUTICS INC - MAY OFFER AND SELL, FROM TIME TO TIME, SHARES OF  COMMON STOCK OF UP TO $1.2 MILLIONSource text:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PTIX","LENZ"],"gpt_icon":0},{"id":"2502567898","title":"Protagenic Therapeutics Inc - May Offer and Sell, From Time to Time, Shares of  Common Stock of up to $1.2 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2502567898","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502567898?lang=en_us&edition=full_marsco","pubTime":"2025-01-10 19:14","pubTimestamp":1736507664,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250110:nFWN3O60PE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PTIX","BK4139"],"gpt_icon":0},{"id":"2493268425","title":"Protagenic Therapeutics Files Prospectus for Shares Sale by Stockholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2493268425","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493268425?lang=en_us&edition=full_marsco","pubTime":"2024-12-21 00:33","pubTimestamp":1734712439,"startTime":"0","endTime":"0","summary":"Protagenic Therapeutics  on Friday filed a registration statement with the US Securities and Exchange Commission for the potential sale of up to about 5.84 million shares by some selling stockholders from \"time to time.\"The company said it is not selling any stock under this prospectus.Price: 0.63, Change: -0.02, Percent Change: -3.08","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PTIX","BK4139","LENZ"],"gpt_icon":0},{"id":"2492416845","title":"Protagenic Therapeutics Inc Files for Offering of up to 5.84 Mln Shares of Common Stock by Selling Stockholders - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2492416845","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492416845?lang=en_us&edition=full_marsco","pubTime":"2024-12-20 19:14","pubTimestamp":1734693254,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241220:nFWN3NL0CQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PTIX","BK4139"],"gpt_icon":0},{"id":"2485521448","title":"BRIEF-Protagenic Therapeutics Inc - On Nov 19, Co Receives Nasdaq Delist Determination Letter","url":"https://stock-news.laohu8.com/highlight/detail?id=2485521448","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485521448?lang=en_us&edition=full_marsco","pubTime":"2024-11-23 05:21","pubTimestamp":1732310510,"startTime":"0","endTime":"0","summary":"Nov 22 (Reuters) - Protagenic Therapeutics Inc   :   * PROTAGENIC THERAPEUTICS INC - ON NOV 19, CO RECEIVES NASDAQ DELIST DETERMINATION LETTERSource text: [ Further company coverage:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNQmain","ON","BK4141","IE00BGHQF748.EUR","IE00BZ199S13.USD","LU1854103824.USD","BK4139",".IXIC","PSQ","LU0724618433.USD","LU0348723411.USD","LU1548497426.USD","IE00BKPKM429.USD","LU2357305700.SGD","BK4585","LU2298322129.HKD","NDAQ","TQQQ","BK4512","BK4588","SQQQ","LU1720051017.SGD","LU2095319765.USD","LU2210149790.SGD","NQmain","LU1861220033.SGD","PTIX","QLD","LU1978683503.SGD","LU0124384867.USD","LU2360107325.USD","LU1854104046.USD","LU2210150020.SGD","IE00B64PRP62.GBP","LU1720051108.HKD","IE00BD6J9T35.USD","BK4112","IE00B3QW5Z07.USD","LU1861215975.USD","LU1861219969.SGD","QID","LU1861214812.USD"],"gpt_icon":0},{"id":"2485214697","title":"Protagenic Therapeutics Inc - on Nov 19, Co Receives Nasdaq Delist Determination Letter","url":"https://stock-news.laohu8.com/highlight/detail?id=2485214697","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485214697?lang=en_us&edition=full_marsco","pubTime":"2024-11-23 05:14","pubTimestamp":1732310093,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241122:nFWN3MT0YO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PTIX"],"gpt_icon":0},{"id":"2481504477","title":"Protagenic Therapeutics Announces Closing of Private Placement for Aggregate Gross Proceeds of $1.275 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2481504477","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481504477?lang=en_us&edition=full_marsco","pubTime":"2024-11-05 21:12","pubTimestamp":1730812320,"startTime":"0","endTime":"0","summary":"NEW YORK, NY / ACCESSWIRE / November 5, 2024 / Protagenic Therapeutics, Inc.  , a leader in biopharmaceutical innovation, announced today that on November 4, 2024 it closed its previously announced private placement pursuant to a purchase agreement  for the purchase and sale of an aggregate of 1,948,295 shares of common stock, series A common stock purchase warrants to purchase an aggregate of 1,948,295 shares of common stock, with an exercise price of $0.64 per share, which are exercisable on the trading day immediately following the Stockholder Approval Date  for a term of eighteen  months from the Stockholder Approval Date, and series B common stock purchase warrants to purchase an aggregate of 1,948,295 shares of common stock with an exercise price of $0.64 per share, which are exercisable on the trading day immediately following the Stockholder Approval Date for a term of five  years from the Stockholder Approval Date. The purchase price of each share of common stock and associate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/protagenic-therapeutics-announces-closing-private-131200289.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PTIX","LENZ","BK4139","PTIXW"],"gpt_icon":0},{"id":"2479723042","title":"Protagenic Therapeutics Prices $1.3 Million Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2479723042","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479723042?lang=en_us&edition=full_marsco","pubTime":"2024-10-30 02:19","pubTimestamp":1730225982,"startTime":"0","endTime":"0","summary":"Protagenic Therapeutics  said Tuesday that it has struck a deal to sell about 1.95 million shares, series A warrants and series B warrants to raise about $1.275 million for working capital.The purchase price of each share and associated warrants will be $0.64, the firm said. It expects to close the offering Nov 4, with Brookline Capital Markets, a division of Arcadia Securities, as the placement agent.The stock was down more than 10% in recent trading.Price: 0.57, Change: -0.07, Percent Change: -10.49","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PTIX","BK4139","LENZ"],"gpt_icon":0},{"id":"2479934283","title":"Protagenic Therapeutics to sell 1.95M shares at 64c in private placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2479934283","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479934283?lang=en_us&edition=full_marsco","pubTime":"2024-10-29 21:36","pubTimestamp":1730208975,"startTime":"0","endTime":"0","summary":"Protagenic Therapeutics (PTIX) has entered into a purchase agreement for the purchase and sale of an aggregate of 1,948,295 shares of common stock,...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/protagenic-therapeutics-to-sell-1-95m-shares-at-64c-in-private-placement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/protagenic-therapeutics-to-sell-1-95m-shares-at-64c-in-private-placement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","PTIX","BK4139"],"gpt_icon":0},{"id":"2479283340","title":"Protagenic Therapeutics Announces Pricing of Private Placement for Aggregate Gross Proceeds of $1.275 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2479283340","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479283340?lang=en_us&edition=full_marsco","pubTime":"2024-10-29 21:27","pubTimestamp":1730208420,"startTime":"0","endTime":"0","summary":"NEW YORK, NY / ACCESSWIRE / October 29, 2024 / Protagenic Therapeutics, Inc.  , a leader in biopharmaceutical innovation, announced today it has entered into a purchase agreement  for the purchase and sale of an aggregate of 1,948,295 shares of common stock , series A common stock purchase warrants to purchase an aggregate of 1,948,295 shares of common stock, with an exercise price of $0.64 per share, which are exercisable on the trading day immediately following the Stockholder Approval Date  for a term of eighteen  months from the Stockholder Approval Date , and series B common stock purchase warrants to purchase an aggregate of 1,948,295 shares of Common Stock with an exercise price of $0.64 per share, which are exercisable on the trading day immediately following the Stockholder Approval Date for a term of five  years from the Stockholder Approval Date. The purchase price of each share of common stock and associated common stock purchase warrants will be $0.64 .","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/protagenic-therapeutics-announces-pricing-private-132700626.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PTIX","PTIXW","BK4139","PTGX","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.protagenic.com","stockEarnings":[{"period":"1week","weight":-0.2522},{"period":"1month","weight":-0.3603},{"period":"3month","weight":-0.6018},{"period":"6month","weight":-0.6901},{"period":"1year","weight":-0.8885},{"period":"ytd","weight":-0.6018}],"compareEarnings":[{"period":"1week","weight":-0.0256},{"period":"1month","weight":-0.0586},{"period":"3month","weight":-0.0455},{"period":"6month","weight":-0.0166},{"period":"1year","weight":0.0694},{"period":"ytd","weight":-0.0455}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.425882},{"month":2,"riseRate":0.428571,"avgChangeRate":0.013845},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.030138},{"month":4,"riseRate":0.5,"avgChangeRate":-0.110468},{"month":5,"riseRate":0.142857,"avgChangeRate":-0.044371},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.016401},{"month":7,"riseRate":0.142857,"avgChangeRate":-0.087978},{"month":8,"riseRate":0.285714,"avgChangeRate":0.036974},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.081142},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.022675},{"month":11,"riseRate":0,"avgChangeRate":-0.041357},{"month":12,"riseRate":0.142857,"avgChangeRate":-0.093492}],"exchange":"NASDAQ","name":"Protagenic Therapeutics Inc","nameEN":"Protagenic Therapeutics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Protagenic Therapeutics Inc(PTIX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Protagenic Therapeutics Inc(PTIX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Protagenic Therapeutics Inc,PTIX,Protagenic Therapeutics Inc股票,Protagenic Therapeutics Inc股票老虎,Protagenic Therapeutics Inc股票老虎国际,Protagenic Therapeutics Inc行情,Protagenic Therapeutics Inc股票行情,Protagenic Therapeutics Inc股价,Protagenic Therapeutics Inc股市,Protagenic Therapeutics Inc股票价格,Protagenic Therapeutics Inc股票交易,Protagenic Therapeutics Inc股票购买,Protagenic Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Protagenic Therapeutics Inc(PTIX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Protagenic Therapeutics Inc(PTIX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction